Global Live Attenuated Vaccines Market By Product Type, By Product Application, By Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2021 To 2029

Published : Q1 2021 | Pages : 200+

Select License Type


Description

Key Companies

GlaxoSmithKline Plc.
Merck & Co.
Novartis International AG
Pfizer Inc.
Astellas Pharma Inc.
Johnson & Johnson
CSL Limited
Emergent BioSolution Inc.
MedImmune LLC
Sanofi
Serum Institute Of India Pvt. Ltd.

Segmentation Covered

By Type
Bacterial
Viral

By Application
Hospitals
Clinics
Research Institutes
Others

By End Use
Geriatrics
Adults
Adolescents
Child

By Vaccines
Measles, mumps, rubella (MMR combined vaccine)
Rotavirus
Smallpox
Chickenpox
Yellow fever

By Region

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

TABLE OF CONTENTS

Chapter 1 Global Live Attenuated Vaccines Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Live Attenuated Vaccines Market
1.4 Restraints for Live Attenuated Vaccines Market
1.5 Opportunities for Live Attenuated Vaccines Market
1.6 Trends for Live Attenuated Vaccines Market
1.7 COVID-19 Impact Assessment on Live Attenuated Vaccines Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Live Attenuated Vaccines Market Overview

2.1 Global Live Attenuated Vaccines Market by Product Type
2.1.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Live Attenuated Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Live Attenuated Vaccines Market by End User
2.2.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Live Attenuated Vaccines Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Live Attenuated Vaccines Market by Region
2.3.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Live Attenuated Vaccines Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Live Attenuated Vaccines Market Outlook (2013-2029)
2.4.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Live Attenuated Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Live Attenuated Vaccines Market Y-o-Y Growth Rate by Region
2.8.2 Global Live Attenuated Vaccines Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Live Attenuated Vaccines Market Y-o-Y Growth Rate by End User
2.9 Global Live Attenuated Vaccines Market Share Comparison (2013-2029)
2.9.1 Global Live Attenuated Vaccines Market Share by Region
2.9.2 Global Live Attenuated Vaccines Market Share by Product Type
2.9.3 Global Live Attenuated Vaccines Market Share by End User

Chapter 3 North America Live Attenuated Vaccines Market Overview

3.1 North America Live Attenuated Vaccines Market by Product Type
3.1.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Live Attenuated Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Live Attenuated Vaccines Market by End User
3.2.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Live Attenuated Vaccines Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Live Attenuated Vaccines Market by Region
3.3.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Live Attenuated Vaccines Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Live Attenuated Vaccines Market Outlook (2013-2029)
3.4.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Live Attenuated Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Live Attenuated Vaccines Market Y-o-Y Growth Rate by Region
3.8.2 North America Live Attenuated Vaccines Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Live Attenuated Vaccines Market Y-o-Y Growth Rate by End User
3.9 North America Live Attenuated Vaccines Market Share Comparison (2013-2029)
3.9.1 North America Live Attenuated Vaccines Market Share by Region
3.9.2 North America Live Attenuated Vaccines Market Share by Product Type
3.9.3 North America Live Attenuated Vaccines Market Share by End User

Chapter 4 Europe Live Attenuated Vaccines Market Overview

4.1 Europe Live Attenuated Vaccines Market by Product Type
4.1.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Live Attenuated Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Live Attenuated Vaccines Market by End User
4.2.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Live Attenuated Vaccines Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Live Attenuated Vaccines Market by Region
4.3.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Live Attenuated Vaccines Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Live Attenuated Vaccines Market Outlook (2013-2029)
4.4.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Live Attenuated Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Live Attenuated Vaccines Market Y-o-Y Growth Rate by Region
4.8.2 Europe Live Attenuated Vaccines Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Live Attenuated Vaccines Market Y-o-Y Growth Rate by End User
4.9 Europe Live Attenuated Vaccines Market Share Comparison (2013-2029)
4.9.1 Europe Live Attenuated Vaccines Market Share by Region
4.9.2 Europe Live Attenuated Vaccines Market Share by Product Type
4.9.3 Europe Live Attenuated Vaccines Market Share by End User

Chapter 5 Asia Pacific Live Attenuated Vaccines Market Overview

5.1 Asia Pacific Live Attenuated Vaccines Market by Product Type
5.1.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Live Attenuated Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Live Attenuated Vaccines Market by End User
5.2.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Live Attenuated Vaccines Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Live Attenuated Vaccines Market by Region
5.3.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Live Attenuated Vaccines Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Live Attenuated Vaccines Market Outlook (2013-2029)
5.4.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Live Attenuated Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Live Attenuated Vaccines Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Live Attenuated Vaccines Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Live Attenuated Vaccines Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Live Attenuated Vaccines Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Live Attenuated Vaccines Market Share by Region
5.9.2 Asia Pacific Live Attenuated Vaccines Market Share by Product Type
5.9.3 Asia Pacific Live Attenuated Vaccines Market Share by End User

Chapter 6 South America Live Attenuated Vaccines Market Overview

6.1 South America Live Attenuated Vaccines Market by Product Type
6.1.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Live Attenuated Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Live Attenuated Vaccines Market by End User
6.2.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Live Attenuated Vaccines Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Live Attenuated Vaccines Market by Region
6.3.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Live Attenuated Vaccines Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Live Attenuated Vaccines Market Outlook (2013-2029)
6.4.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Live Attenuated Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Live Attenuated Vaccines Market Y-o-Y Growth Rate by Region
6.8.2 South America Live Attenuated Vaccines Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Live Attenuated Vaccines Market Y-o-Y Growth Rate by End User
6.9 South America Live Attenuated Vaccines Market Share Comparison 2013-2029
6.9.1 South America Live Attenuated Vaccines Market Share by Region
6.9.2 South America Live Attenuated Vaccines Market Share by Product Type
6.9.3 South America Live Attenuated Vaccines Market Share by End User

Chapter 7 MEA Live Attenuated Vaccines Market Overview

7.1 MEA Live Attenuated Vaccines Market by Product Type
7.1.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Live Attenuated Vaccines Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Live Attenuated Vaccines Market by End User
7.2.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Live Attenuated Vaccines Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Live Attenuated Vaccines Market by Region
7.3.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Live Attenuated Vaccines Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Live Attenuated Vaccines Market Outlook (2013-2029)
7.4.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Live Attenuated Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Live Attenuated Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Live Attenuated Vaccines Market Y-o-Y Growth Rate by Region
7.8.2 MEA Live Attenuated Vaccines Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Live Attenuated Vaccines Market Y-o-Y Growth Rate by End User
7.9 MEA Live Attenuated Vaccines Market Share Comparison (2013-2029)
7.9.1 MEA Live Attenuated Vaccines Market Share by Region
7.9.2 MEA Live Attenuated Vaccines Market Share by Product Type
7.9.3 MEA Live Attenuated Vaccines Market Share by End User

Chapter 8 Global Live Attenuated Vaccines Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
GlaxoSmithKline Plc.
Merck & Co.
Novartis International AG
Pfizer Inc.
Astellas Pharma Inc.
Johnson & Johnson
CSL Limited
Emergent BioSolution Inc.
MedImmune LLC
Sanofi
Serum Institute Of India Pvt. Ltd.

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

FOR MORE INFORMATION

Have a Question? Email us at

[email protected]

Or call us on

+1(925)478-7203

Credence Research Reports